ライフサイエンスコーパス: adjusted odds ratio

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ession and calculated effectiveness based on adjusted odds ratio.

2 as lower among individuals aged 15-24 years (adjusted odds ratio 0.55, 95% CI 0.45-0.68) and mobile i

3 ndividual n-3 DPA was associated with a 36% (adjusted odds ratio 0.64; 95% CI 0.42-0.96; P = 0.042) a

4 s was not significantly associated with AKI (adjusted odds ratio 0.80, 95% CI 0.63-1.00, P = 0.057).

5 s were not associated with anastomotic leak (adjusted odds ratio 0.85, 95% CI 0.58-1.21, P = 0.382).

6 ence interval 0.62-1.58) or acute rejection (adjusted odds ratio 0.89, 95% confidence interval 0.40-1

7 ipants used opioids in the prior seven days: Adjusted Odds ratio = 0.10 (95% CI: 0.01 - 1.29, p = .08

8 ling for pre-operative moderate-severe pain: Adjusted odds ratio = 0.25 (95% CI: 0.07 - 0.95, p < .05

9 0.31-1.00) or early and late VD sufficiency (adjusted odds ratio = 0.36; 95% CI = 0.15-0.81) had a lo

10 cy, those with early or late VD sufficiency (adjusted odds ratio = 0.56; 95% CI = 0.31-1.00) or early

11 ence of an association between BCG and LTBI (adjusted odds ratio = 0.70; 95% confidence interval, .56

12 val [CI] = 0.80-0.98, P = 0.019) and female (adjusted odds ratio = 0.81, 95% CI = 0.71-0.93, P = 0.00

13 e donor kidneys transplanted into both male (adjusted odds ratio = 0.89, 95% confidence interval [CI]

14 eceive revascularization (0.4% versus 5.8%, [adjusted odds ratio =0.09; 95% CI, 0.05-0.16]; P<0.0001)

15 d with the presence of an endotracheal tube (adjusted odds ratio, 0.13; 95% CI, 0.1-0.2) and urinary

16 pre-extracorporeal membrane oxygenation pH (adjusted odds ratio, 0.21; 95% CI, 0.09-0.49; p < 0.001)

17 ndependence were Injury Severity Score >=25 (adjusted odds ratio, 0.24 [95% confidence interval, 0.09

18 ificantly reduced in the intervention group (adjusted odds ratio, 0.25; 95% confidence interval, .07-

19 0.13; 95% CI, 0.1-0.2) and urinary catheter (adjusted odds ratio, 0.28; 95% CI, 0.1-0.6).

20 educed odds of 90-day all-cause readmission (adjusted odds ratio, 0.2; 95% confidence interval, 0.08-

21 ed with the fourth quartile (first quartile: adjusted odds ratio, 0.40 [95% CI, 0.29-0.55]; second qu

22 % CI, 1.04-2.63]), lowest for those married (adjusted odds ratio, 0.50 [95% CI, 0.33-0.76]), and incr

23 , 0.40 [95% CI, 0.29-0.55]; second quartile: adjusted odds ratio, 0.60 [95% CI, 0.47-0.77]; third qua

24 1.17 to 1.62), lower odds of bleeding gums (adjusted odds ratio, 0.62; 95% CI, 0.54 to 0.70), but no

25 associated with lower in-hospital mortality (adjusted odds ratio, 0.72 per 10 gxmin/m(2) higher [95%

26 not have WLST (32.3% versus 50.7%, P=0.002; adjusted odds ratio, 0.73 [95% CI, 0.60-0.89]).

27 pression symptoms between ages 3 to 8 years (adjusted odds ratio, 0.73; 95% confidence interval, 0.57

28 designated DNR (31.3% versus 49.9%, P=0.005; adjusted odds ratio, 0.74 [95% CI, 0.60-0.91]) or did no

29 o, 0.60 [95% CI, 0.47-0.77]; third quartile: adjusted odds ratio, 0.76 [95% CI, 0.63-0.91]; P < 0.001

30 h reduced risk of alcohol-related cirrhosis (adjusted odds ratio, 0.76; P=.0027); conversely, the min

31 eath on admission to ICU of greater than 5% (adjusted odds ratio, 0.77; 95% confidence interval, 0.70

32 lower in women (22.5% versus 36.3%, P<0.001; adjusted odds ratio, 0.78 [95% CI, 0.66-0.93]; P=0.005).

33 1.01; 95% CI 0.67-1.54; P=0.95) and 1-year (adjusted odds ratio, 0.80; 95% CI, 0.52-1.22; P=0.30) al

34 had a severe or fatal course of the disease (adjusted odds ratio, 0.83 [95% CI, 0.63 to 1.10] for ARB

35 ated with the use of physiologic assessment (adjusted odds ratio, 0.86; 95% CI, 0.63-1.18).

36 scharge delay and was lowest at 48-72 hours (adjusted odds ratio, 0.87; 95% confidence interval, 0.79

37 nd 38 of 159 (24%) in the talc slurry group (adjusted odds ratio, 0.91 [95% CI, 0.54-1.55]; P = .74;

38 er was associated with lower PICU mortality (adjusted odds ratio, 0.94; 95% CI, 0.90-0.98).

39 n with Covid-19 among case patients overall (adjusted odds ratio, 0.95 [95% confidence interval {CI},

40 1.42 [95% CI, 1.24-1.64]) but not in NSTEMI (adjusted odds ratio, 0.97 [95% CI, 0.83-1.13]).

41 nt at 14-days controlling for other factors (adjusted odds ratio: 0.41; 95% confidence interval, .22

42 lications did not differ between the groups (adjusted odds ratio: 0.96; 95% CI: 0.77 to 1.19; p = 0.6

43 ere 23% less likely to be accepted post-KAS (adjusted odds ratio: (0.61) 0.77(0.98) , P = .03).

44 nt compared with 160 (28%) in the GHE group (adjusted odds ratio=0.01, 95% CI 0.003-0.012, p<0.0001).

45 000 period to 26.4% in the 2013-2016 period (adjusted odds ratio=0.18, 95% CI=0.13-0.27).

46 26% lower odds of continuation of treatment (adjusted odds ratio=0.74, 95% CI=0.69, 0.79).

47 dds of guideline-concordant acute treatment (adjusted odds ratio=0.79, 95% CI=0.73, 0.84) and 26% low

48 te acute-phase treatment and 19% lower odds (adjusted odds ratio=0.81; 95% CI=0.73, 0.89) of psychoth

49 substance use disorders had 13% lower odds (adjusted odds ratio=0.87, 95% CI=0.82, 0.91) of adequate

50 ciated with reduced mental health treatment (adjusted odds ratio=0.92, 95% CI=0.87, 0.98).

51 compared with nonsevere acute kidney injury; adjusted odds ratio 1.04; 95% CI, 1.01-1.08; p = 0.04).

52 of 13 706 in the non-HIV self-testing group (adjusted odds ratio 1.30, 95% CI 1.03-1.65; p=0.03).

53 were: increased age (per 10 years; partially adjusted odds ratio 1.84, 95% CI 1.53-2.21), male sex (1

54 k than non-Hispanic white or other partners (adjusted odds ratio 1.89, 95% CI 1.09-3.27) and lower in

55 F was not a significant predictor of 30-day (adjusted odds ratio, 1.01; 95% CI 0.67-1.54; P=0.95) and

56 day of extracorporeal membrane oxygenation (adjusted odds ratio, 1.01; 95% CI, 1.00-1.02; p = 0.009)

57 xtracorporeal membrane oxygenation duration (adjusted odds ratio, 1.01; 95% CI, 1.00-1.03; p = 0.02),

58 nd the control group (2.52%; 291 of 11,523) (adjusted odds ratio, 1.02; 95% confidence interval [CI],

59 associated with changes in 90-day mortality (adjusted odds ratio, 1.03 [95% confidence interval {CI},

60 not at increased risk of dying in-hospital (adjusted odds ratio, 1.03; 0.98-1.07).

61 f in-hospital mortality (23.0% versus 21.7%; adjusted odds ratio, 1.11 [95% CI, 1.07-1.16]; P<0.001).

62 st clinical predictor for use of ticagrelor (adjusted odds ratio, 1.13 [95% CI, 1.09-1.18]) and prasu

63 atio, 1.29; 95% CI, 1.03-1.61; p = 0.024 and adjusted odds ratio, 1.13; 95% CI, 1.01-1.28; p = 0.042,

64 ciated with significantly greater mortality (adjusted odds ratio, 1.15; 95% CI, 1.03-1.29; p = 0.011)

65 pital mortality (28.2% vs. 19.7%; P < 0.001; adjusted odds ratio, 1.17 [95% CI, 1.02-1.33]; primary p

66 9; 95% CI, 1.05-1.13; p < 0.001) and anemia (adjusted odds ratio, 1.17; 95% CI, 1.03-1.33; p = 0.019)

67 1.02-1.33]; primary propensity-matched model adjusted odds ratio, 1.19 [95% CI, 1.02-1.40]).Conclusio

68 ltivariable generalized estimating analysis (adjusted odds ratio, 1.27 [95% CI, 1.19-1.35]).

69 io, 1.13 [95% CI, 1.09-1.18]) and prasugrel (adjusted odds ratio, 1.27 [95% CI, 1.21-1.34]) compared

70 t acquired impairment at hospital discharge (adjusted odds ratio, 1.29; 95% CI, 1.03-1.61; p = 0.024

71 increased risk of alcohol-related cirrhosis (adjusted odds ratio, 1.30; P=.020).

72 rane oxygenation circuit mechanical failure (adjusted odds ratio, 1.33; 95% CI, 1.02-1.74; p = 0.03),

73 with an increased risk of 30-day mortality (adjusted odds ratio, 1.33; 95% CI, 1.16-1.53), and this

74 , current upper respiratory tract infection (adjusted odds ratio, 1.35; 95% CI, 1.12 to 1.63), cigare

75 for matched non-ICU patients (2.6% vs. 1.5%; adjusted odds ratio, 1.37 [95% CI, 1.19-1.58]).Conclusio

76 er odds of excellent self-rated oral health (adjusted odds ratio, 1.37; 95% CI, 1.17 to 1.62), lower

77 is difference remained significant in STEMI (adjusted odds ratio, 1.42 [95% CI, 1.24-1.64]) but not i

78 patients versus 64% of usual care patients (adjusted odds ratio, 1.43 [95% CI, 1.21-1.70]).

79 encephalopathy, and mechanical ventilation (adjusted odds ratio, 1.43; 95% CI, 1.08-1.88; p = 0.012)

80 showed a similar, yet nonsignificant trend (adjusted odds ratio, 1.44; 95% confidence interval, .81-

81 cardiorespiratory severity at presentation (adjusted odds ratio, 1.48 [95% CI, 1.16-1.90]).

82 4; p = 0.03), and renal replacement therapy (adjusted odds ratio, 1.49; 95% CI, 1.14-1.94; p = 0.004)

83 r bleeding had higher in-hospital mortality (adjusted odds ratio, 1.49; 95% CI, 1.16-1.92).

84 CI, 1.30 to 2.54), attending pubs or clubs (adjusted odds ratio, 1.54; 95% CI, 1.28 to 1.86), and in

85 ociated with the 3-month functional outcome (adjusted odds ratio, 1.570; 95% CI, 0.721-3.419; p = 0.3

86 asing number of vessels injured per patient (adjusted odds ratio, 1.6 per one-vessel increase [95% CI

87 Female sex (adjusted odds ratio, 1.61; 95% CI, 1.16-2.22; p = 0.004)

88 95% CI, 1.28 to 1.86), and intimate kissing (adjusted odds ratio, 1.65; 95% CI, 1.33 to 2.05).

89 ere highest for those not currently working (adjusted odds ratio, 1.66 [95% CI, 1.04-2.63]), lowest f

90 nce interval, 1.07-3.93] and immunomodulator adjusted odds ratio, 1.81 [95% confidence interval, 1.22

91 -1.03; p = 0.02), renal replacement therapy (adjusted odds ratio, 1.81; 95% CI, 1.30-2.52; p < 0.001)

92 ; 95% CI, 1.29 to 2.83), water-pipe smoking (adjusted odds ratio, 1.82; 95% CI, 1.30 to 2.54), attend

93 er likelihood of readmission within 30 days (adjusted odds ratio, 1.83 [95% CI, 1.38-2.34]).

94 CI, 1.24-2.92), multiple prior malignancies (adjusted odds ratio, 1.86; 95% CI, 1.15-2.99), and hemop

95 5% CI, 1.30-2.52; p < 0.001), and hemolysis (adjusted odds ratio, 1.87; 95% CI, 1.11-3.16; p = 0.02)

96 ith increased odds of in-hospital mortality (adjusted odds ratio, 1.88; 95% CI, 1.27-2.78).

97 ell transplant, congenital immunodeficiency (adjusted odds ratio, 1.90; 95% CI, 1.24-2.92), multiple

98 5; 95% CI, 1.12 to 1.63), cigarette smoking (adjusted odds ratio, 1.91; 95% CI, 1.29 to 2.83), water-

99 with a higher likelihood of vasopressor use (adjusted odds ratio, 1.98; 95% CI, 1.45-2.71) and higher

100 p < 0.001), and mortality (40.0% vs. 24.9%; adjusted odds ratio: 1.88; 95% confidence interval: 1.27

101 ed to likelihood of mental health treatment (adjusted odds ratio=1.01, 95% CI=0.98, 1.03).

102 f less severe localized bacterial infection (adjusted odds ratio=1.6, 95% CI=1.1-2.3).

103 ngly associated with psychosis in offspring (adjusted odds ratio=1.8, 95% CI=1.2-2.7) and varied by s

104 t vs 9% of patients in the bisoprolol group (adjusted odds ratio, 10.3 [95% CI, 4.0 to 26.6]; P < .00

105 mber of intravitreal injections (AMD and PCV adjusted odds ratio, 12.1 [P = 0.001] and 12.5 [P = 0.00

106 the development of any cardiac abnormality (adjusted odds ratio 2.59, 95% confidence interval 1.03-6

107 Higher injury grade (adjusted odds ratio, 2.0 per one-grade increase [95% con

108 ities, and concomitant medications (anti-TNF adjusted odds ratio, 2.05 [95% confidence interval, 1.07

109 r likelihood of discharge to long-term care (adjusted odds ratio, 2.06 [95% CI, 1.50-2.64]) and highe

110 rolled beneficiaries increased between 2004 (adjusted odds ratio, 2.09 [95% CI, 2.08-2.10]) and 2017

111 y during hospitalization (16.8% versus 3.8%; adjusted odds ratio, 2.1 [95% CI, 1.7-2.5]; P<0.001) and

112 CI, 0.63-0.91]; P < 0.001) and the Midwest (adjusted odds ratio, 2.15; 95% CI, 1.13-4.07; P = 0.02),

113 d survive with favorable neurologic outcome (adjusted odds ratio, 2.21; 95% CI, 1.04-4.67; p = 0.036)

114 s ratio, 2.09 [95% CI, 2.08-2.10]) and 2017 (adjusted odds ratio, 2.22 [95% CI, 2.21-2.23]) (P < .001

115 ore likely to survive to hospital discharge (adjusted odds ratio, 2.31; 95% CI, 1.10-4.83; p = 0.025)

116 , 2.15; 95% CI, 1.13-4.07; P = 0.02), South (adjusted odds ratio, 2.71; 95% CI, 1.23-5.99; P = 0.01),

117 95), and hemophagocytic lymphohistiocytosis (adjusted odds ratio, 2.79; 95% CI, 1.36-5.71) were assoc

118 000 period to 40.9% in the 2013-2016 period (adjusted odds ratio=2.88, 95% CI=2.06-4.03).

119 effect of multisystemic bacterial infection (adjusted odds ratio=2.9, 95% CI=1.3-5.9) was nearly twic

120 independently associated with current mania (adjusted odds ratio 3.49, 95% confidence interval (CI) 2

121 orted practicing receptive anal intercourse (adjusted odds ratio 3.90; P < .001) after adjusting for

122 .71; 95% CI, 1.23-5.99; P = 0.01), and West (adjusted odds ratio, 3.01; 95% CI, 1.21-7.54; P = 0.02)

123 eased in cases triggered by 3 or more foods (adjusted odds ratio, 3.07; 95% CI, 1.38-6.82; P = .006).

124 99), and hemophagocytic lymphohistiocytosis (adjusted odds ratio, 3.09; 95% CI, 1.91-4.98) were assoc

125 opoietic cell transplant, liquid malignancy (adjusted odds ratio, 3.15; 95% CI, 2.09-4.74), congenita

126 medical) patient (adjusted odds ratio, 3.29; 95% CI, 2.72-3.97).

127 increased in FPIES triggered by cow's milk (adjusted odds ratio, 3.41; 95% CI, 1.21-9.63; P = .02) a

128 I, 3.84-12.53), multiple prior malignancies (adjusted odds ratio, 3.54; 95% CI, 1.80-6.95), and hemop

129 d baseline VA of 20 logMAR letters or fewer (adjusted odds ratio, 3.8 and 10.6 for AMD and PCV, respe

130 le to have a significant effect on SSI rate (adjusted odds ratio, 3.815; 95% confidence interval, 1.1

131 ltivariable logistic regression, female sex (adjusted odds ratio, 3.83; 95% confidence interval, 1.65

132 age predicting a false-positive examination (adjusted odds ratio, 3.86; 95% confidence interval, 1.1-

133 of mechanical ventilation (22.8% vs. 11.9%; adjusted odds ratio: 3.64; 95% confidence interval: 2.56

134 ies was among children aged <5 years (12.5%; adjusted odds ratio, 33.2; 95% CI, 6.6-603.2), and the h

135 h MLVI even after adjusting for deprivation (adjusted odds ratio 4.0 95% confidence interval, 1.7-10.

136 terococcus had the highest 1-year mortality (adjusted odds ratio 4.34 [95% CI, 3.12-6.05] and 3.41 [9

137 model, measured fever >=38 degrees Celsius (adjusted odds ratio = 4.6, 95% confidence interval [CI]

138 presence in children less than 3 years old (adjusted odds ratio, 4.55; 95% CI, 3.1-6.6).

139 of noncarriers had LSMs of 7.1 kPa or more (adjusted odds ratio, 4.8; 95% confidence interval, 2.0-1

140 ssociation with rural versus urban location (adjusted odds ratio, 5.22; 95% confidence interval [CI],

141 000 period to 51.4% in the 2013-2016 period (adjusted odds ratio=5.05, 95% CI=3.65-7.01).

142 CI, 2.09-4.74), congenital immunodeficiency (adjusted odds ratio, 6.94; 95% CI, 3.84-12.53), multiple

143 .41; 95% CI, 1.21-9.63; P = .02) and banana (adjusted odds ratio, 7.63; 95% CI, 2.10-27.80; P = .002)

144 provider-initiated testing and counselling (adjusted odds ratio 8.52, 95% CI 3.98-18.24) or optimise

145 9) mutation in adenocarcinoma for discovery (adjusted Odds Ratio = 8.82, P = 1.18 x 10(-15)) and repl

146 go was among children aged 5-9 years (16.4%; adjusted odds ratio, 8.1; 95% CI, 3.6-21.8).

147 last 12 months were city residence at birth [adjusted odds ratio (95% confidence interval) 2.66 (1.42

148 Adjusted odds ratios (95% CI; p-value) for infant deaths

149 Comparing 4th to 1st quartiles, adjusted odds ratios (95% confidence interval) for hospi

150 as associated with higher rhinitis severity (adjusted odds ratio [95% CI] for a 10 mug/m(3) increase

151 ) and no increase in reliever prescriptions (adjusted odds ratio, 95% CI, p-value: ICS inhaler dose =

152 thma were positively associated with KC with adjusted odds ratios (adjusted OR 8.69, 95% CI 3.74-20.1

153 The median adjusted odds ratio and bayesian probability of superior

154 adjusted odds ratios and 95% confidence intervals for th

155 om pregnancies complicated by pre-eclampsia (adjusted odds ratio (aOR) 1.46, 95% CI: 1.12-1.90) and F

156 r risk of functional and cognitive declines [adjusted odds ratio (aOR) 1.52, 95% confidence interval

157 >=5 months with violations vs 27.2% with 0, adjusted odds ratio (AOR) 2.86 [95% confidence interval

158 was directly associated with frailty: CFS 5 adjusted odds ratio (aOR) 3.18 [95% confidence interval

159 In adjusted models, IDU status [Adjusted Odds Ratio (AOR) 3.92 (95% CI: 3.43-4.48)] was

160 was more strongly associated with diabetes (Adjusted Odds Ratio (AOR) = 6.16, 95%CI: 3.15-12.0) than

161 ltivariable proportional odds model, with an adjusted odds ratio (aOR) greater than 1.0 indicating mo

162 Adjusted odds ratio (aOR) of discharge disposition and a

163 There was high geographical variability: the adjusted odds ratio (aOR) of receiving parenteral steroi

164 A higher number of siblings [adjusted odds ratio (aOR): 1.39; 95% CI: 1.11, 1.77], in

165 culty appointment and K/RPG award, reporting adjusted odds ratios (AOR) and 95% confidence intervals

166 Adjusted odds ratios (AOR) for hospital admissions, proc

167 logistic regression models and expressed as adjusted odds ratios (aOR) with 95% confidence intervals

168 onal logistic regression was used to compute adjusted odds ratios (aOR) with 95% confidence intervals

169 Adjusted odds ratios (aOR)(95% CI) among participants wi

170 was more common for mothers who were single (adjusted odds ratio [AOR; adjusting for country, materna

171 lower in patients on VKA (156 of 247 [63%]; adjusted odds ratio [aOR] 0.67; 95% CI 0.50-0.90) and pa

172 Hispanic (adjusted odds ratio [aOR] 0.72; P < .001) and black pati

173 an those with no physical activity (K6 5-12: adjusted odds ratio [AOR] 0.86, 95% confidence interval

174 eated on the date of their UTI consultation (adjusted odds ratio [aOR] 1.13, 95% CI 0.97-1.32, p-valu

175 nt included: prior fluoroquinolone exposure (adjusted odds ratio [aOR] 1.38), chronic renal disease (

176 ciated with female sex in the index patient (adjusted odds ratio [aOR] 1.56 [95% CI 1.38-1.77], p<0.0

177 med household contact were at greatest risk (adjusted odds ratio [aOR] 4.82 [95%CI 3.45-6.72]).

178 was independently associated with mortality (adjusted odds ratio [aOR] 6.05; 95% confidence interval

179 r alcohol intoxication self-reported by men (adjusted odds ratio [AOR] = 0.56, 95% CI 0.36-0.85, p =

180 eive ATG than HCV- recipients (living donor, adjusted odds ratio [aOR] = 0.640.770.91; deceased donor

181 ear experience of physical (couples' UBL arm adjusted odds ratio [AOR] = 1.00, 95% confidence interva

182 ovements over time in retention in HIV care (adjusted odds ratio [aOR] = 1.03; 95% confidence interva

183 aviors, such as non-adherence to medication (adjusted odds ratio [AOR] = 1.07, 95% confidence interva

184 ter likelihood of an article being reshared (adjusted odds ratio [AOR] = 1.19, 95% confidence interva

185 rved increased odds of general symptom days (adjusted odds ratio [aOR] = 1.40 [95% C = 1.02-1.92]), m

186 (favorable CT = 56% vs favorable CTP = 57%, adjusted odds ratio [aOR] = 1.91, 95% confidence interva

187 ar death was associated with severe atrophy (adjusted odds ratio [aOR] = 2.54, 95% confidence interva

188 An increasing length of stay (adjusted odds ratio [aOR] per day, 1.03; P = .006), expo

189 status and recent exposure to glycopeptides (adjusted odds ratio [aOR], > 2 for MRSA and VREfc/VREfm)

190 comorbidities, and hospital effects, women (adjusted odds ratio [aOR], 0.45 [0.41-0.49]), black pati

191 OVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86).

192 dent hepatic decompensation (6.5% vs. 11.6%, adjusted odds ratio [AOR], 0.63; 95% confidence interval

193 ikely to experience poor pregnancy outcomes (adjusted odds ratio [aOR], 0.83 [95% confidence interval

194 a lower abnormal interpretation rate (AIR) (adjusted odds ratio [AOR], 0.85; P < .001), which remain

195 hospital mortality was lower in the Midwest (adjusted odds ratio [aOR], 0.96 [95% CI, 0.93-0.98]; P<0

196 ely to be USA300 in patients who were older (adjusted odds ratio [aOR], 0.97 per year [95% confidence

197 etween dual therapy and the primary outcome (adjusted odds ratio [aOR], 1.07; 95% confidence interval

198 ds of financial hardship from medical bills (adjusted odds ratio [aOR], 1.27 [95% CI, 1.18-1.36]) or

199 Hyperlipidemia (adjusted odds ratio [AOR], 1.3; 95% confidence interval

200 le analysis, IC adults had higher mortality (adjusted odds ratio [aOR], 1.46; 95% confidence interval

201 ociated with preoperative arterial diameter (adjusted odds ratio [aOR], 1.50 per 1-mm increase; 95% c

202 ificantly associated with preterm birth (age-adjusted odds ratio [aOR], 1.50; 95% confidence interval

203 RT DRMs was 10% in cases and 5% in controls (adjusted odds ratio [aOR], 1.53 [95% confidence interval

204 Higher PDC (adjusted odds ratio [AOR], 1.74 per 1-level increase in

205 in genetic testing as a PLD: age >=35 years (adjusted odds ratio [aOR], 1.75; 95% confidence interval

206 rrected visual acuity (BCVA) <=0.1 (decimal, adjusted odds ratio [aOR], 1.82; P < 0.001); pseudoexfol

207 ciated with current employment or schooling (adjusted odds ratio [aOR], 1.83 [95% confidence interval

208 oauthorship rose substantially (first author adjusted odds ratio [aOR], 1.93; 95% confidence interval

209 predictor of consensus anal hHSIL diagnosis (adjusted odds ratio [aOR], 10.34 [95% CI, 3.47-30.87]).

210 SA to have no underlying medical conditions (adjusted odds ratio [aOR], 2.06; 95% confidence interval

211 Age was associated with incident LSILs (adjusted odds ratio [aOR], 2.10 per 10-year increase in

212 tions included tumor size greater than 3 cm (adjusted odds ratio [AOR], 2.4 [95% CI: 1.2, 4.5]; P = .

213 independently associated with clinical cure (adjusted odds ratio [aOR], 2.63; 95% confidence interval

214 pital mortality, particularly for cirrhosis (adjusted odds ratio [aOR], 2.67; 95% confidence interval

215 within the first 14 days (16.3% versus 4.8%; adjusted odds ratio [aOR], 3.7 [95% CI, 1.62-8.43]) but

216 he rate of congenital infection without HIG (adjusted odds ratio [AOR], 5.2; P < .0001), a 1.8-fold i

217 re >6 times higher in women with anal hrHPV (adjusted odds ratio [aOR], 6.08 [95% confidence interval

218 s associated with 6-fold greater odds of HL (adjusted odds ratio [aOR], 6.18; 95% CI, 3.04-12.57), wi

219 Low economic status (adjusted odds ratio [AOR]3.8 (95%CI 1.3-11.4), being 37-

220 t failure (aHR: 0.521.001.91, P > 0.9), DGF (adjusted odds ratio [aOR]: 0.580.861.27, P = 0.4), acute

221 fferent comparing LNG-IUS to C-IUD across 6 (adjusted odds ratio [AOR]: 0.78, 95% confidence interval

222 tests than the usual care arm (71% vs. 20%, adjusted odds ratio [AOR]: 13.38; 95% confidence interva

223 and age were associated with VIA positivity (adjusted Odds Ratio [aOR]: 3.53, 95% CI: 1.10 to 11.29;

224 requent AECRS with statistically significant adjusted odds ratios (aORs) after controlling for age, r

225 acid-fast-bacilli smear-positivity to obtain adjusted odds ratios (aORs) and 95% CIs.

226 We used random forest models to calculate adjusted odds ratios (aORs) and 95% confidence intervals

227 e following were associated with the highest adjusted odds ratios (aORs) for long-term use: older age

228 The age, site, and co-infection adjusted odds ratios (aORs) for moderate-to-severe diarr

229 lations of FSWs with HSV-2 prevalence < 25%, adjusted odds ratios (AORs) of HIV infection increased f

230 Adjusted odds ratios (aORs) were computed by adjusted lo

231 and dialysis requirement, AKI recovery, and adjusted odds ratios (aORs) with mortality.

232 ociated with decreased risk of AD diagnosis [adjusted odds ratios (AORs): 0.76; 95% confidence interv

233 -days was 35% and associated with older age (adjusted odds ratio for 13-17 vs < 3 yr, 2.1; 95% CI, 1.

234 th participants with no education, the fully adjusted odds ratio for cognitive impairment was 0.57 (9

235 3 yr, 2.1; 95% CI, 1.5-3.1) and male gender (adjusted odds ratio for females, 0.76; 95% CI, 0.61-0.95

236 episodes and simultaneous detection of HEV (adjusted odds ratio for the detection of virus in stools

237 ningitidis included later year of schooling (adjusted odds ratio for year 12 vs. year 10, 2.75; 95% C

238 st quintile of DASH score, the multivariable-adjusted odds ratios for mid-frequency and high-frequenc

239 The adjusted odds ratios for mortality were 0.93 (95% CI, 0.

240 The mutually adjusted odds ratios for the top compared with the botto

241 Adjusted odds ratios for vaccination with 1, 2, and 3 do

242 tive design, VE was estimated as 1 minus the adjusted odds ratio from a logistic regression model tha

243 ed an annual decline in the illness severity adjusted odds ratio (odds ratio) of hospital mortality,

244 ntiretroviral therapy was associated with an adjusted odds ratio of 0.72 (95% confidence interval, .6

245 4) was strongly associated with SCD, with an adjusted odds ratio of 1.56 (95% CI, 1.37-1.77) per 1-un

246 the lowest) had an adjusted odds ratio of 2.66 (95% confidence interval [CI

247 s associated with HCV seroconversion with an adjusted odds ratio of 5.8 (95%CI;1.8-18.1).

248 re was an annual decline in illness severity adjusted odds ratio of discharge home among trauma patie

249 The adjusted odds ratio of falling within 90 days of biometr

250 logistic regression was used to estimate the adjusted odds ratio of influenza vaccination in people w

251 The adjusted odds ratios of cardiopulmonary and noncardiopul

252 t significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411-8.997], P < 10

253 ignificantly more likely to have daily pain [adjusted odds ratio (OR) 2.30, 95% confidence interval (

254 d 70% lower odds of diarrhea [100 m vs. 10 m adjusted odds ratio (OR) = 0.55, 95% credible interval (

255 had lower odds of having candida stomatitis (adjusted odds ratio (OR) = 0.68, p = 0.0035) and oral ha

256 associated with severe periodontitis with an adjusted odds ratio (OR) of 2.10 (95% confidence interva

257 ontrols who were hospitalized with COVID-19 (adjusted odds ratio (OR), 0.86; 95% confidence interval

258 nts' preoperative physical status, providing adjusted odds ratios (OR(adj)) and adjusted absolute ris

259 Adjusted odds ratios (OR) for each diagnosis were calcul

260 n and rural area had lower odds ratio of KC (adjusted odds ratio [OR] 0.86, 95% confidence interval [

261 with a 12% reduction of breast cancer risk (adjusted odds ratio [OR] 0.88; 95% confidence interval [

262 al status (improvement per 10 mm Hg increase adjusted odds ratio [OR] 0.90 [95% CI 0.87-0.94], p<0.00

263 APP care had higher rates of HCC screening (adjusted odds ratio [OR] 1.23, 95% confidence interval 1

264 in 160 (39%) of 409 patients among controls (adjusted odds ratio [OR] 1.49 [95% CI 1.10-2.03]; p=0.01

265 roup vs 21 [32%] of 65 in the control group; adjusted odds ratio [OR] 1.74, 95% CI 0.81-3.74).

266 ents in the standard GVHD prophylaxis group (adjusted odds ratio [OR] 3.49 [95% CI 1.60-7.60]; p=0.00

267 ot treated during the previous round of MDA (adjusted odds ratio [OR] 3.60, 95% CI 3.08-4.20 for chil

268 Sjogren syndrome made every day a challenge (adjusted odds ratio [OR] 3.81, 95% confidence interval [

269 CI 2.74-3.38, p < 0.001), poorer attainment (adjusted odds ratio [OR] 3.92, 95% CI 3.63-4.23, p < 0.0

270 ed with development of small vessel disease (adjusted odds ratio [OR] = 1.47 [95% CI = 1.05-2.06]) bu

271 ificant association between exposure to ATV (adjusted odds ratio [OR] = 1.54; 95% confidence interval

272 was associated with older age (multivariable-adjusted odds ratio [OR] = 1.59 per 10 years; 95% CI = 1

273 4) had increased risk for incident delirium (adjusted odds ratio [OR] = 3.7 [95% confidence interval

274 during hospitalization (D-dimer >2500 ng/mL, adjusted odds ratio [OR] for thrombosis, 6.79 [95% CI, 2

275 se functional outcome at 90 days (mRS = 0-2, adjusted odds ratio [OR] per 30 minutes increase in time

276 associated with decreased 30-day mortality (adjusted odds ratio [OR], 0.53 [95% confidence interval

277 tly higher recall rate compared with DM/DBT (adjusted odds ratio [OR], 1.06; adjusted 95% CI: 1.01, 1

278 munocompromised status (90-day multivariable adjusted odds ratio [OR], 1.56; 95% confidence interval

279 with COVID-19 disease: non-White ethnicity (adjusted odds ratio [OR], 2.17; 95% confidence interval

280 higher rates of the 4-way endpoint at 96 h (adjusted odds ratio [OR]: 1.40; 95% confidence interval

281 tly associated with the primary outcome (CFS adjusted odds ratio, OR, 2.51, 95% confidence interval,

282 ion to estimate unadjusted and multivariable-adjusted odds ratios (ORs) and 95% confidence intervals

283 g LT versus medications were evaluated using adjusted odds ratios (ORs) for age, gender, previous cat

284 0.02; control group: 9.2% [34 of 368]) with adjusted odds ratios (ORs) of 2.80 (95% confidence inter

285 We calculated adjusted odds ratios (ORs) of receiving daily PDE5i trea

286 n of participants undergoing mammography and adjusted odds ratios (ORs) of undergoing mammography wit

287 Logistic regression yielded adjusted odds ratios (ORs) per SD higher usual levels of

288 Age-standardized detection rates and age-adjusted odds ratios (ORs) were calculated.

289 d present data with the summary statistic of adjusted odds ratios (ORs) with 95% CIs (fixed effects f

290 s negatively associated with efavirenz (IPTW adjusted odds ratio per 5 years 0.73, 95% confidence int

291 endently associated with hospital mortality (adjusted odds ratio per ml/cm H(2)O increase, 0.988; 95%

292 ssion and the patient's follow-up interview (adjusted odds ratio per month, 1.16 [95% CI, 1.08-1.24])

293 ted with tobacco use disorder comorbidities (adjusted odds ratio range=0.96-0.97).

294 and number of adverse childhood experiences (adjusted odds ratio range=1.04-1.18) were significantly

295 quency of sexual orientation discrimination (adjusted odds ratio range=1.08-1.10), number of stressfu

296 1.08-1.10), number of stressful life events (adjusted odds ratio range=1.25-1.43), and number of adve

297 The adjusted odds ratios used to derive rVE estimates were e

298 Adjusted odds ratios were determined by multivariable lo

299 Adjusted odds ratios were higher among participants with

300 increased severity of rhinitis, with similar adjusted odds ratios whatever the level of severity.

301 Binary logistic regression model and adjusted odds ratio with 95% confidence level was used t